These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19352347)

  • 1. Making a difference.
    Nat Biotechnol; 2009 Apr; 27(4):297. PubMed ID: 19352347
    [No Abstract]   [Full Text] [Related]  

  • 2. Trouble at the FDA: can we fix the problems affecting you and your patients?
    Henley E
    J Fam Pract; 2006 Apr; 55(4):301-4. PubMed ID: 16608668
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory science as culture: contested two-dimensional values at the US FDA.
    Abraham J
    Sci Cult (Lond); 2002 Sep; 11(3):309-35. PubMed ID: 15971364
    [No Abstract]   [Full Text] [Related]  

  • 4. A turbulent year at the agency.
    Ratner M
    Nat Biotechnol; 2006 Feb; 24(2):145-51. PubMed ID: 16465153
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical guidelines and guidelines on ethics are not the same.
    Friedman JH
    Med Health R I; 2007 Feb; 90(2):38-9. PubMed ID: 17500247
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reporting issues for managers.
    Sperling RL
    Home Healthc Nurse Manag; 1999; 3(6):26-9. PubMed ID: 10876507
    [No Abstract]   [Full Text] [Related]  

  • 7. New FDA regulation to improve safety reporting in clinical trials.
    Sherman RB; Woodcock J; Norden J; Grandinetti C; Temple RJ
    N Engl J Med; 2011 Jul; 365(1):3-5. PubMed ID: 21651388
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 9. Blueprint for a stronger Food and Drug Administration.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2006 Oct; 355(17):1821. PubMed ID: 17030844
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on "Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting" by Linder et al.
    Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1216-7. PubMed ID: 20981885
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 12. Protecting the health of the public--Institute of Medicine recommendations on drug safety.
    Psaty BM; Burke SP
    N Engl J Med; 2006 Oct; 355(17):1753-5. PubMed ID: 17030843
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reaction reporting.
    Somberg JC
    Am J Ther; 2000 Aug; 7(4):227-8. PubMed ID: 11486155
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA's sentinel network: a monumental task.
    Young D
    Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of leadership once again plagues US drug agency.
    Wadman M
    Nat Med; 2005 Nov; 11(11):1128. PubMed ID: 16270050
    [No Abstract]   [Full Text] [Related]  

  • 16. Remedies needed to address the pathology in reporting adverse reactions and Food and Drug Administration use of reports.
    Wolfe SM
    J Gen Intern Med; 2003 Jan; 18(1):72-3. PubMed ID: 12534769
    [No Abstract]   [Full Text] [Related]  

  • 17. What ails the FDA?
    Marcus DM
    N Engl J Med; 2005 Jun; 352(24):2554. PubMed ID: 15962405
    [No Abstract]   [Full Text] [Related]  

  • 18. Making all clinical trials available for review: any impact on clinical decisions?
    Smith GH
    J Am Pharm Assoc (2003); 2005; 45(1):7-8. PubMed ID: 15730109
    [No Abstract]   [Full Text] [Related]  

  • 19. The United States Pharmacopeia Veterinary Practitioners' Reporting Program.
    Meyer EK; Becker SC
    J Am Vet Med Assoc; 1996 Feb; 208(3):361-3. PubMed ID: 8575965
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of adverse drug reaction reporting in veterinary and human medicine.
    Bukowski JA; Wartenberg D
    J Am Vet Med Assoc; 1996 Jul; 209(1):40-5. PubMed ID: 8926206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.